EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLE ORGANISATION DATE TOPIC
Parliament’s balanced stand on Unitary SPC regulation rewards innovation via an efficient Unitary SPC system that protects against access to medicines delays Medicines for Europe 28 Feb 2024 InfoSociety
Court decision on Supplementary Protection Certificate (SPC) manufacturing waiver risks undermining its use Medicines for Europe 18 Jan 2024 InfoSociety
Now or never: Europe must seize the Pharma Legislation opportunity to ensure patient access to continuous innovation for existing medicines Medicines for Europe 07 Nov 2023 Health & Consumers
A step forward for the secure supply of medicines and manufacturing and for public health Medicines for Europe 25 Oct 2023 Health & Consumers
Time for the EU to take steps: a medicines security act is needed for health security Medicines for Europe 02 Oct 2023 Health & Consumers
A streamlined, digital regulatory framework is the foundation for equitable access to medicines Medicines for Europe 27 Sep 2023 Health & Consumers
European Parliament lends its support to a fair cost-based approach on EMA fees Medicines for Europe 30 Jun 2023 Health & Consumers
Generic medicine pricing reforms needed in Slovakia to ensure supply for patients Medicines for Europe 23 Jun 2023 Health & Consumers
EBA and Medicines for Europe signed a memorandum of agreement to accelerate Ukraine's integration into the EU pharmaceutical market Medicines for Europe 22 Jun 2023 Health & Consumers
Off-patent medicines ready to drive pharma policy reform for equitable access, availability and security of medicines supply Medicines for Europe 15 Jun 2023 Health & Consumers
Access to medicines and security of supply should be central to EU pharma and IP legislation reforms in Europe Medicines for Europe 13 Jun 2023 Health & Consumers
EU must bolster biosimilar medicines policy to increase equity of access and bring much needed savings to healthcare budgets Medicines for Europe 25 May 2023 Health & Consumers
Medicines for Europe joins the Antimicrobial (AMR) One Health Network Medicines for Europe 09 May 2023 Health & Consumers
Future of pharmaceutical policy rests on secure supply of essential medicines Medicines for Europe 03 May 2023 Health & Consumers
Patients should benefit from greater access under new patent package proposals Medicines for Europe 28 Apr 2023 Health & Consumers
Reaction to EU Pharmaceutical legislation: Timely and equitable access for patients and security of supply essential for reform Medicines for Europe 27 Apr 2023 Health & Consumers
Harmonised bioequivalence guideline paves the way for global generic medicine development and access to medicines Medicines for Europe 26 Apr 2023 Health & Consumers
Market reforms needed to secure essential antibiotics against AMR, report says Medicines for Europe 16 Feb 2023 Health & Consumers
EU can do more for equitable access to medicines Medicines for Europe 13 Jan 2023 Health & Consumers
Billions more euros to re-invest in better healthcare thanks to biosimilar medicines Medicines for Europe 14 Dec 2022 Health & Consumers
2022 Health at a Glance Report highlights the need to rethink investments in health after the COVID-19 pandemic Medicines for Europe 05 Dec 2022 Health & Consumers
Giving medicines a new life: EU should foster patients’ access to Value Added Medicines Medicines for Europe 30 Nov 2022 Health & Consumers
Pharmaceutical legislation reforms must support equitable access to medicine in Central and Eastern Europe and security of medicines supplies Medicines for Europe 17 Nov 2022 Health & Consumers
Proposals on wastewater treatment will jeopardise patient access to medicines without helping green transition Medicines for Europe 27 Oct 2022 Health & Consumers
Energy Council (TTE) – Medicines for Europe Open letter to European Energy Ministers and responsible European Commissioners on inflation and energy costs impacting the supply of essential generic medicines Medicines for Europe 28 Sep 2022 Health & Consumers
EMA/HMA share definitive EU-wide position on biosimilar medicines interchangeability Medicines for Europe 20 Sep 2022 Health & Consumers
Medicines for Europe warns strongly against energy rationing for medicines production Medicines for Europe 20 Jul 2022 Health & Consumers
The off-patent medicines industry is a vital part of the solution for healthcare resilience Medicines for Europe 30 Jun 2022 Health & Consumers
Smart reform of EU pharma and IP legislation key to boosting access to essential medicines Medicines for Europe 30 Jun 2022 Health & Consumers
EU can do more for patients with smart use of biosimilar medicines Medicines for Europe 29 Apr 2022 Health & Consumers

Pages